famotidine has been researched along with Campylobacter Infection in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, M | 1 |
| Pajares, JM | 1 |
| Jimenez, ML | 1 |
| Lopez-Brea, M | 1 |
1 trial available for famotidine and Campylobacter Infection
| Article | Year |
|---|---|
Effect of acid inhibition on Campylobacter pylori.
Topics: Adult; Campylobacter; Campylobacter Infections; Duodenitis; Famotidine; Female; Gastric Acid; Gastri | 1988 |